Wiki SBN Secretariaat

<a href="">kit chelsea dream league for cheap</a> <a href="">jordan retro 8 champagne</a> <a href="">miami dolphins military hat target</a> <a href="">chuteira nike elastico pro iii tf</a> <a href="">san diego padres star wars hat ukulele chords</a> <a href="">mercurial superfly size 5 2017</a> [url=]makrisberns[/url]


Filed in: Main.HomePage · Modified on : Fri, 18 Jun 21

The global digital biomarkers market is projected to be worth USD 10.38 Billion by 2027, according to a current analysis by Emergen Research. The digital biomarkers market is observing rapid growth attributed to the growing incidence of chronic diseases. The swiftly growing burden of chronic diseases across the globe are fueling the market growth. According to the statics released by WHO (World Health Organization), the burden of chronic diseases is projected to grow by 57.0% by the year 2020 from 2001. Developing nations are expected to be highly impacted, contributing to 60.0% of the global burden of chronic diseases. An increase in healthcare expenditure and increased funding for healthcare R&D are significantly driving the digital biomarkers' market growth. The healthcare expenditure in the US reached USD 3.60 trillion in 2018, an increase of 4.6% from the previous years. This rise in spending is, to some extent, faster as compared to the increase in 2017 from 2016.

The latest industry intelligence research on the digital biomarkers market offers a repository of valuable data on the size, share, and growth rate of the digital biomarkers market for the forecast period, 2020 - 2027. Importantly, examination of various facets of the industry including but not limited to production volume, product sales, demand and supply assessment and forecast for the period, 2020 - 2027 aim at offering business owners a competitive edge over their rivals. The study further conducts a qualitative evaluation of various driving forces expected to shape the future of the industry during the estimated period.

Read more@

Key Highlights From The Report

In September 2020, Koneksa, a firm engaged in the development and implementation of patient-specific digital biomarkers for use in the drug development process, declared the completion of Series B funding round worth USD 16.0 Million. Koneska intends to deploy the fund for the integration of wearables and other patient-specific technologies into clinical research by expanding its digital platform.

The low cost and improved scalability of digital biomarkers based on smartphone apps help in facilitating a prospective wealth of social, behavioral, psychological, and environmental data that were formerly inaccessible.

Recent psychiatric assessment approaches are resource-intensive and consume substantial time for evaluation. Digital biomarkers development is considered to hod immense prospects in allowing time-sensitive, scalable, and affordable assessment of symptom changes and psychiatric diagnosis.

North America held a significant digital biomarker market share in 2091 attributed to the high penetration of smartphones and wearable devices, along with the growing prevalence of lifestyle-related diseases, which, in turn, persuades consumers to monitor their vital signs for a better insight into health conditions. Key participants include AliveCor Inc., Bayer AG, Evidation Health Inc., Fitbit Inc., Happify Health, Koninklijke Philips NV, Neurotrack Technologies Inc., GlaxoSmithKline Inc., Novartis International AG, and F. Hoffmann-La Roche Ltd., among others.

Request For Free Sample@

System Component Outlook (Revenue, USD Billion; 2017-2027) Data Collection Tools Digital Platforms Mobile Apps Desktop-Based Software Wearable Biosensors Data Integration Systems

Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027) Cardiovascular Disease Sleep and Movement Disease Neurodegenerative Disorders Psychiatric Disorder Gastrointestinal Disease Respiratory Disease Diabetes Others

End-Users Outlook (Revenue, USD Billion; 2017-2027) Pharmaceutical Companies Providers Payers

Regional Outlook (Revenue, USD Billion; 2017-2027) North America Europe Asia Pacific Latin America MEA

Table of Content

Chapter 1. Methodology & Sources

    1.1. Digital Biomarkers Market Definition
    1.2. Digital Biomarkers Market Research Scope
    1.3. Digital Biomarkers Market Methodology
    1.4. Digital Biomarkers Market Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
   1.5. Digital Biomarkers Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Digital Biomarkers Market Segmentation & Impact Analysis


About Emergen Research

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us: Eric Lee Web: E-mail:

Powered by PmWiki